I notice a lot of soul searching going on here these past few days which is a good thing, I suppose. But still nobody is asking the right questions about the who, how and why?

Who is really behind it?
How could it go on for so long?
Why was it done this way?

Is this CEO still active in the White House Historical Society? She needs to apply some of this good work to NWBO’s website.

https://www.whitehouse.gov/j6/

https://www.prnewswire.com/news-releases/first-patients-enrolled-in-groundbreaking-brain-cancer-study-at-nationally-recognized-academic-medical-center-302653738.html

Yeah, because those alleged shorts haven’t made enough money. You’re out to lunch, Flip.

>>I think he’s a parasite, and likely trying to save some shorts right now. I wouldn’t be surprised if there is some shake out between now and end of month, but not for what AF is claiming.

>>This is to most powerfully immunise people against their tumours, Pollard explains. Because today’s standard-of-care chemotherapy can damage the immune system, giving the viral immunotherapy first, means the immune activity and memory are activated before the system is compromised.

https://news.cancerresearchuk.org/2026/01/06/the-switch-and-the-trojan-horse-how-viral-vectors-and-synthetic-enhancers-could-change-glioblastoma-treatment/

Another major advantage to this timeline is that roughly three weeks after a trial participant is given Trogenix’s immunotherapy, they will have their tumour removed. Interrogating the tissue that the neurosurgeon excises will give an immediate indication of whether the AAV is working. The team will be able to check for cell loss, for expression of HSV-TK and IL-12, and for other robust indicators that the immune system is responding as planned.

Will someone please tell that Jefferson Starship NWBO disciple cover band to perform this one next.

The Who - Won't Get Fooled Again

Aren’t you outraged that the company did not provide a replay or transcript?

>>The ASM was a chance for them to desktop that clear and firm commitment and they didn’t seem to, at least as I understood it.

Hey GoodGuyBill, that IT agreement I posted for you as an example of a proper transparent arrangement now comes with this PR too. Have you ever seen similar copy in a PR coming from NWBO about UCLA?

>>Marker Therapeutics, Inc. (Nasdaq: MRKR) is a clinical-stage immuno-oncology Company with the worldwide exclusive license of Multi-Antigen Targeted T cells (also referred to as Multi-Antigen Recognizing T cells, or MAR-T cells, by Marker), a technology developed at Baylor College of Medicine for the treatment of hematologic and solid tumors. A research team from Baylor College of Medicine has now published groundbreaking work in Nature Medicine investigating Multi-Antigen Targeted T cells in patients with pancreatic cancer.

These financiers always manage to somehow hit the mark no matter. Any idea how they moved it to .32 this time?

Guess you’ve forgotten your own post.🤷🏻‍♂️

Interesting, thanks. This part stood out to me:

>>Government policy
In November 2025, the government said that there were no plans to expand flash-freezing facilities for brain cancer tissue.

So now they’re not even getting back to NICE? Can’t make it up.

Flip, Many years ago I always confused you and Happy because I thought your postings were so similar. One of you wrote probably ten years ago that you had a letter addressed to the SEC ready to go. Which one of you was that?

Widow calls for frozen tissue law change after husband’s brain tumour death

https://www.independent.co.uk/news/health/glioblastoma-owains-law-brain-tumour-b2895857.html

If L were close to approval wouldn’t this have happened already?

“We are calling on Government to ensure that fresh-frozen tissue storage is available in all possible instances around the UK.

“The technology is there – let’s use it to make a difference.”

Investors have been saying that since around 2012. And who knows what she said with her stem cell endeavors before that?

>>Linda Powers is highly unlikely to say that because she knows she will lose whatever credibility she has left if she doesn’t follow through.’

Yep, DOW approaching 50k and NWBO disciples kept tunnel visioned losing their as—-. It’s unreal that they don’t demand answers.

Everything of importance swiftly moved off the first page….Such an obvious illusion.

Ask it if it's possible LP waits around to take advantage of the progression of messaging? After all this company was born around the creation of the Internet. 

I don’t know about the other two gurus but Thermo is having vision problems.

They’re doing the crazy gyro dance, SirP. 10 cents to 20 cents will be 100% gain shoutouts!

Poor Bankz lost about 99.9% of his cash.

Three articles regarding DC vaccine enhancements and not a peep. 🤷🏻‍♂️

https://zivic.art/featured/the-investor-gregory-zivic.html?product=tote-bag

https://zivic.art/featured/the-investor-gregory-zivic.html

🤣. If you’re up 40% on this tiny move what % do you call the move from $1 to 25 cents? See how that works?

Good to see the move but still just 30 million market cap, so a long way to go if the therapy is seen as a real possible player.

Oh boy, looks like Flopper and the other disciples have begun their chest pounding routine, once again. Amazing what ten cents can do.

“Routine”…And LP couldn’t tell her shareholders that why?

Right but getting it to .29 required a pump somewhere so don’t sell shares until conversion. And don’t dismiss LG’s trust selling in all this because if you’re right that there’s no hope for this stock, they should be selling now.

I’m not arguing your Yorkville theory as it’d fall under “Dilute after instead of during New Year pump”.

Possible reasons not in any particular order:

Dilute after instead of during New Year pump
Advent actually has cash and revenues in 2025
Financiers took the week off
Can’t dilute while LG options are being converted and sold.
They no longer need cash due to new partner
Woodford-like angel
Buyout imminent
LP wants to keep her word and stop diluting at 25 cents but 30 to 40 cents is ok.
Some good settlement in the spoofing case.

And one piece of bad news will get it to 10 cents in an hour. You know I’ve called the share price bottoms right all along. I genuinely had some hope for Advent pushing the stock price up but now it sure doesn't look like that’s going to happen.

https://www.nature.com/articles/s41590-025-02376-4

https://www.technologynetworks.com/tn/news/how-dying-tumor-cells-alert-the-immune-system-to-fight-cancer-408303

https://phys.org/news/2025-12-nanozigzags-biomaterial-cancer-immunotherapy-efficacy.html

Wow, nice! You called the five cents! Everyone knows the pump has to come. Then the next piece of news and probably down to ten cents. But hey, at least LP can dilute at 30 or 40 cents and keep her word. 🤷‍♀️

They used to call this a “Dead cat bounce” but you don’t hear that much anymore.

60 day timing on the blocker with a 30 day window to the next filing? We shall see.

AF called on the SEC to get involved and semi accused UCLA of conspiring, did he not? Or is that just a normal yawn of day around here for an influential biotech journalist to go that far?

Unlikely to be moving up if real good news were imminent as they’d do one last quick shake out.

Could be that AF motivated someone to end this?

They probably forget about the wash rules.

Still waiting for anyone to dig up anything that might resemble what $consultants$ are allegedly telling her?

>>What is noteworthy, and I would say this is based on what our UK advisors have said to us, we don’t have firsthand knowledge, but our advisors have said that there are quite a number of other companies who are in the situation that we’re in and are very long into the application process, can be as much as two years like we are. It’s not just us. That is a comfort factor, and it was helpful to hear that from our advisors. I don’t have firsthand knowledge, but they’re experts and they see the landscape.

If this second hand transcript is correct, LP really really highlighted the risk factors like she hasn’t before, I noticed.

>>You should read our SEC filings that contain a non-exhaustive list of risk factors. There are lots of factors, risk factors, and other factors that can cause actual results to differ materially from our forward-looking statements and whatever we may currently anticipate. So just solid, solid on the table and very clear for everyone.

Let me start by saying that this is going to be an informal discussion. It’s going to contain forward-looking statements. And we need to be clear in our disclaimer that all statements other than statements of historical fact are forward-looking statements. So we expect, we hope, we plan, we anticipate. All of these are forward-looking statements. You should not rely upon forward-looking statements.